Ben Haim Shlomi

JFrog CEO Ben Haim Shlomi sold 93,072 shares for $7,873,827.16 via pre-arranged 10b5-1 plan on 2026-06-08

Ben Haim Shlomi, JFrog's Chief Executive Officer, executed three separate sales totaling 93,072 shares for $7,873,827.16 on 2026-06-08 under a pre-arranged 10b5-1 trading plan adopted on 2026-02-19, meaning this sale was scheduled rather than discretionary. The blended average price of $84.60 sits above the current price of $81.26, though the stock has appreciated 15.2% over the past 30 days and 94.2% over the past 90 days. His post-transaction holdings of 4.66M shares represent a -2.0% net reduction. The company is growing revenue at +24.1% year-over-year but remains unprofitable with $-8.3M net income in the latest full fiscal year. His prior five trades at FROG have shown mixed return profiles (ranging from +11.8% to +60.7% on 30-day and 90-day horizons), while his cross-ticker track record shows an average 90-day return of +25.5%, though this transaction's predetermined scheduling limits the relevance of timing analysis.

CEO Ben Haim Shlomi sold 43,056 shares of FROG at $86.54 on 2026-06-02 for $3.7M; still retains 4.75M shares.

Ben Haim Shlomi, CHIEF EXECUTIVE OFFICER, sold 43,056 shares (43.1K shares) at $86.54, representing a modest -0.9% net change to his post-transaction holdings of 4.75M shares. The sale occurred while FROG traded near its 52-week high—only -5.9% below the $89.16 peak—and follows a sharp 30-day surge of +59.5% and 90-day rally of +104.0%. His prior five trades at FROG (all sells) generated positive 90-day returns ranging from 35.1% to 58.4%, yet achieved zero well-timed outcomes by the 90-day standard, meaning the stock continued rising after each sale. The company remains unprofitable with a -$8.3M net income, though revenue grew 24.1% year-over-year. This sale occurs amid strong price momentum rather than evident distress, and the small reduction in an otherwise substantial CEO position does not materially alter his exposure to the company.

CEO Ben Haim Shlomi sold 51,237 shares of FROG at $75.02 on 2026-05-29 under 10b5-1 plan; stock now $88.05.

CEO Ben Haim Shlomi sold 51,237 shares at $75.02 on 2026-05-29, executed under a pre-arranged 10b5-1 trading plan adopted on 2025-03-03, meaning this was a scheduled transaction rather than discretionary. Post-transaction holdings remain substantial at 4,794,364 shares. The stock has appreciated significantly since the sale date (current price $88.05 versus transaction price $75.02), and his prior sales at FROG have also been followed by gains: five previous trades at this ticker showed 30-day returns ranging from +0.4% to +36.8% and 90-day returns from +35.1% to +58.4%. The company generated $153,977,000.00 in quarterly revenue with +24.1% annual growth but remains unprofitable with net income of $-8,267,000.00 over its most recent full fiscal year. The scheduled nature of this execution removes any timing inference; the consistently positive post-sale price movements in his FROG transaction history are observed facts but do not reflect discretionary decision-making in this filing.

CEO Ben Haim Shlomi sells 48,763 shares of FROG at $75.04 via pre-arranged 10b5-1 plan

Ben Haim Shlomi, as CEO, sold 48,763 shares (48.8K shares) for $3,659,175.52 ($3.7M) on 2026-05-26 at $75.04, reducing his holdings by 1.0% to 4,845,601 shares (4.85M shares). This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-03-03 and therefore represents a scheduled, non-discretionary sale rather than a discretionary market decision. The sale occurs when FROG stock is trading at $72.77, or -3.1% from its 52-week high of $75.08, and within a context where the stock has appreciated +59.9% over 30 days and +81.2% over 90 days. Across his prior five trades at FROG, Ben Haim Shlomi's sales have been followed by 30-day returns ranging from +0.4% to +36.8% and 90-day returns ranging from +35.1% to +58.4%, though the company remains unprofitable on a full-year basis with net income of $-8,267,000.00 ($-8.3M) despite quarterly revenue of $153,977,000.00 ($154.0M) and annual revenue growth of +24.1%.

FROG CEO Shlomi Ben Haim sells 25,000 shares for $1.3M amid stock recovery; consistent with pattern of frequent dispositions.

Shlomi Ben Haim, JFrog's CEO, has sold approximately 25,000 shares worth $1.3 million, continuing a persistent pattern of open-market dispositions that dominates his Form 4 activity over the past three years. The stock is currently trading well below its highs after a recent rally, but Ben Haim's historical results at this ticker show conflicting timing signals—his prior sales were well-timed in the near term as the stock dipped afterward, yet poorly timed over longer horizons as the stock recovered substantially. This sale adds to an overwhelming pattern of selling across his filing history, with over 60 prior open-market sales and no open-market purchases recorded, suggesting consistent capital reduction rather than any conviction play. The company remains unprofitable on an annual basis despite revenue growth, creating an uncertain backdrop where the CEO's repeated selling may reflect ordinary portfolio management or liquidity needs, but does not align with the capital-building activity typical of executives confident in near-term catalysts.

CEO Shlomi Ben Haim sells 25,000 FROG shares for $1.2M at $48.88 avg; stock now -35.6% from 52-week high

Shlomi Ben Haim, CEO of JFrog Ltd, executed 2 separate sales totaling 25,000 shares for $1,221,886.03 on 2026-04-07, reducing his holdings to 4.74M shares. The transaction occurred at a blended average price of $48.88, while the stock currently trades at $44.46—a -35.6% distance from its 52-week high of $68.98 and down 25.0% over 90 days. At the same ticker, Ben Haim has conducted 5 prior open-market trades in recent weeks (Feb-Mar 2026), predominantly selling; 4 of the 5 most recent transactions show near-term positive 30-day returns (+20.7%, +23.3%, +21.0%), yet none of the measurable 90-day outcomes show the well-timed pattern (negative 90-day returns post-sale). The company remains unprofitable (net income $-16.4M in the latest quarter) despite 24.1% annual revenue growth, and the stock has declined significantly from recent peaks. This latest sale occurs after multiple sequential sales within the prior month and warrants monitoring as a pattern of consistent insider selling during a period of stock decline and operational loss.

CEO Shlomi Ben Haim sold 25,000 shares of FROG at $45.07 on 2026-03-25 (now $43.34); stock -37.2% from 52-week high.

CEO Shlomi Ben Haim sold 25,000 shares at $45.07, reducing his position to 4,765,249 shares (net -0.5%). The stock has since declined to $43.34, trading -37.2% below its 52-week high of $68.98, though it has recovered 11.8% over the prior 30 days. This sale occurred in a cluster: the CEO executed three separate sells between 2026-02-05 and 2026-03-06, with prior FROG sales showing 30-day declines of -22.5% and -21.8%, though these outcomes postdate his selling decisions. Fundamentally, the company remains unprofitable with a net loss of $16,431,000 in the latest quarter, despite generating $136,907,000 in quarterly revenue with 24.1% annual growth. The timing of this sale against a steep valuation drawdown and the company's negative net income warrants attention to whether operational challenges or macroeconomic headwinds are driving the CEO's recent selling pattern.

CEO Shlomi Ben Haim sold 25,363 shares for $1,052,660.66 at $41.50 blended avg; stock down -38.7% (90-day)

Shlomi Ben Haim, Chief Executive Officer, executed 2 separate sales totaling 25,363 shares for $1,052,660.66 on 2026-03-06, reducing holdings by 0.5%. The stock currently trades at $42.18, down -38.8% from its 52-week high of $68.98 and down -12.1% over the past 30 days. At his same-ticker FROG holdings, Ben Haim has sold 5 times in recent months; of the 4 measurable 30-day outcomes, all showed negative returns (-22.5%, -21.8%, -19.6%, +0.7%), with his December sale followed by a -35.1% 90-day decline. His cross-ticker track record across 20 prior sells shows a 31.25% well-timed rate at the 90-day mark and a positive 1.6% average 90-day return—meaning his prior sales across other stocks were on average followed by further declines, though this current FROG sale's timing cannot yet be evaluated. JFrog remains unprofitable (full-year net income was negative) despite +24.1% annual revenue growth, adding fundamental context to a phase of CEO selling activity following a steep stock decline.

FROG CEO sold 71,841 shares at $40.15; stock now $39.19 (-43.2% from 52-week high)

Shlomi Ben Haim sold 71,841 shares at $40.15 on 2026-03-02, representing a 1.5% reduction in his 4.82M-share post-transaction holdings. The timing is notable: the stock has declined 43.2% from its 52-week high of $68.98 and is down 29.4% over the 30 days preceding this sale, suggesting the CEO executed this sale into a deteriorating price environment. Examining his cross-ticker track record, Ben Haim's 20 prior open-market sells averaged a 14.0% 90-day return with a 7.69% well-timed rate, indicating his sells have historically preceded further declines. However, at FROG specifically, his 5 prior trades show mixed near-term outcomes: the most recent measurable sale on 2026-01-07 saw a -19.6% 30-day return, while earlier December sales had -3.4% and -0.9% 30-day outcomes. The company remains unprofitable (net income of $-16.4M over the full fiscal year) despite 24.1% annual revenue growth, which may underpin the stock's sharp decline from its 52-week highs.

CEO Shlomi Ben Haim sold 25,000 shares of FROG for $1,298,058.00 on 2026-02-05 amid -13.5% 30-day decline

Shlomi Ben Haim, CEO of JFrog Ltd, executed 2 separate sales totaling 25,000 shares for $1,298,058.00 ($1.3M) at an average price of $51.92, representing a 0.5% reduction in his post-transaction holdings of 4.74M shares. The timing occurs as the stock has declined -13.5% over the past 30 days and trades -25.7% below its 52-week high, while the company posted a negative net income of $-16.4M in its most recent quarter. His prior trades at FROG show mixed near-term outcomes: 4 of 5 prior sales occurred in December 2025 with returns ranging from -3.4% to +0.7% over 30 days, though the most recent January 2026 sale deteriorated by -19.6%, neither establishing a pattern of well-timed exits. The cross-ticker track record demonstrates a 0.00% well-timed rate across 20 historical sells, indicating these sales have not consistently preceded further declines.